Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracycline-based protocol. A report from the Spanish group PETHEMA

Saved in:
Bibliographic Details
Published in:Haematologica (Roma) 2001-08, Vol.86 (8), p.807-813
Main Authors: HERNANDEZ, Jesus Maria, MARTIN, Guillermo, DIAZ-MEDIAVILLA, Joaquin, GONZALEZ, Marcos, GONZALEZ-SAN MIGUEL, José David, PEREZ-EQUIZA, Katy, RIVAS, Concha, ESTEVE, Jordi, DEL CARMEN ALVAREZ, Maria, ODRIOZOLA, Jesus, RIBERA, José Maria, SANZ, Miguel Angel, GUTIERREZ, Norma Carmen, CERVERA, José, FERRO, Maria Teresa, CALASANZ, Maria José, MARTINEZ-CLIMENT, José Angel, LUNO, Elisa, TORMO, Mar, RAYON, Consuelo
Format: Article
Language:English
Subjects:
Antineoplastic agents
Biological and medical sciences
Chemotherapy
Hematologic and hematopoietic diseases
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Pharmacology. Drug treatments
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0390-6078
1592-8721